Biopeople is acknowledged as a European Cluster Organisation with excellent management and performance. Come and Join Us.
Samarbejder med videninstitutioner støttes med friske kontanter (InnoBooster)! Hvis du har virksomhed i Region Midtjylland og du er interesseret eller har spørgsmål er du velkommen til at kontakte Per Spindler. Downloads: Informationsflyer.
Annual SIBER conference at Copenhagen Business School on 4-6 June 2015
The Society for International Bioentrepreneurship Education and Research - SIBER - is emerging as an important forum for developing this academic training and research. This field covers a unique and important set of issues that are not addressed in main stream university education for entrepreneurship.
Everywhere the demand for truly radical and disruptive innovation is apparent. To meet this demand a different strategy may be applied in different settings. A good starting point is a clear understanding of what we mean when we talk about disruptive and radical innovation. In this context radical and disruptive innovation describes the entire process of developing an idea into a technology, product or service that makes existing technologies, products or services obsolete. When discussing the preconditions for making radical innovation many people visualize the genius (es) coming up with the brilliant ideas and raising the potentials. However, most radical innovations are only radical in their effect, not in their origin.
The Capital Region of Denmark and the municipalities in the region inaugurate Copenhagen EU Office in Brussels on 1 June 2015. The office will help public and private organizations getting EU funding for ambitious innovation projects.
Participants from the hospitals, the municipalities, the Regions, the Ministry and other institutions as well as private companies dealing with health, biomed and welfare technology had accepted the invitation to attend an afternoon meeting at University of Copenhagen to learn about a new Nordic initiative and a report on living labs and test beds.
When Biopeople and Astra Zeneca invited researchers from the Universities and small and medium sized companies with an interest in Astra Zeneca’s therapy areas in April this year, the intention was to identify possible mutual interest areas between the multinational pharmaceutical company and the Danish biotech eco system. The outcome of the meeting was that Astra Zeneca actually identified projects and researchers which they want to explore further.
5 entries found